Pediatric Drugs

Papers
(The TQCC of Pediatric Drugs is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Vaccine Hesitancy: A Growing Concern58
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents52
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus45
The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials41
Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review41
Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature37
Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy35
Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients34
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-231
Postoperative Nausea and Vomiting in Pediatric Patients29
Postoperative Pain Management in Pediatric Spinal Fusion Surgery for Idiopathic Scoliosis27
Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus25
Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient24
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review20
Immunotherapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges19
Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children19
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial18
Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents18
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria18
An Update on CFTR Modulators as New Therapies for Cystic Fibrosis18
Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects18
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance18
The Use of Linaclotide in Children with Functional Constipation or Irritable Bowel Syndrome: A Retrospective Chart Review16
Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses16
Viloxazine: Pediatric First Approval16
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study16
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting15
Phentermine/Topiramate: Pediatric First Approval15
Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review14
Ranibizumab: A Review in Retinopathy of Prematurity14
Lidocaine Infusions for Pain Management in Pediatrics14
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years13
Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands13
Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial13
Why and How Should We Treat Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome?12
Adherence to Medication During Transition to Adult Services12
Managing Patient Pressure to Prescribe Antibiotics in the Clinic12
External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study11
Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy11
Targeted Therapy for Pediatric Psoriasis11
Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis10
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis10
Sodium Thiosulfate: Pediatric First Approval10
Pain Management in Children: NSAID Use in the Perioperative and Emergency Department Settings9
Metamizole Use in Children: Analysis of Drug Utilisation and Adverse Drug Reactions at a German University Hospital between 2015 and 20209
A Mixed-Methods Analysis of Medication Safety Incidents Reported in Neonatal and Children’s Intensive Care9
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations9
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients9
Impact of Antiseizure Medications on Appetite and Weight in Children9
Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses9
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clin8
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia8
Pharmacological Management of Pediatric Pustular Psoriasis8
Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?8
Characteristics of Reported Pediatric Medication Errors in Northern Ireland and Use in Quality Improvement8
The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders8
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis8
Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart7
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study7
Eosinophilic Esophagitis: Update on Diagnosis and Treatment in Pediatric Patients7
Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis7
Lonapegsomatropin: Pediatric First Approval7
Interleukin-1 Blockade in Systemic Juvenile Idiopathic Arthritis7
Practical Challenges—Use of Paracetamol in Children and Youth Who are Overweight or Obese: A Narrative Review7
Teriflunomide: Pediatric First Approval7
Haloperidol and Quetiapine for the Treatment of ICU-Associated Delirium in a Tertiary Pediatric ICU: A Propensity Score-Matched Cohort Study7
Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review7
0.028252124786377